Turn Therapeutics (TTRX) Shares Issued (2024 - 2026)

Turn Therapeutics' Shares Issued history runs 3 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Shares Issued changed N/A year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.9 million, up 23.16% from the prior year.
• Shares Issued slipped to $1.6 million in Q1 2026 per TTRX's latest filing, from $1.9 million in the prior quarter.
• Across five years, Shares Issued topped out at $3.0 million in Q3 2025 and bottomed at $1.6 million in Q4 2024.
• The 3-year median for Shares Issued is $1.8 million (2025), against an average of $2.0 million.
• Biggest YoY gain for Shares Issued was 23.16% in 2025; the steepest drop was 23.16% in 2025.
• Year by year, Shares Issued stood at $1.6 million in 2024, then gained by 23.16% to $1.9 million in 2025, then decreased by 15.97% to $1.6 million in 2026.
• Per Business Quant, the three latest TTRX Shares Issued figures stand at $1.6 million (Q1 2026), $1.9 million (Q4 2025), and $3.0 million (Q3 2025).